ArticleFrontiers in endocrinology2023

Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease.

Anne Gulbins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.